4 studies found for:    canagliflozin | Sitagliptin | Phase 3
Show Display Options
Rank Status Study
1 Completed
Has Results
The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Canagliflozin;   Drug: Sitagliptin;   Drug: Metformin immediate release
2 Completed
Has Results
The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Sitagliptin 100 mg;   Drug: Canagliflozin 300 mg;   Drug: Metformin;   Drug: Sulphonylurea
3 Completed
Has Results
The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Canagliflozin;   Drug: Sitagliptin;   Drug: Metformin;   Drug: Pioglitazone
4 Completed
Has Results
The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin;   Drug: Placebo;   Drug: Sitagliptin

Indicates status has not been verified in more than two years